These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24315005)

  • 1. A Cost-Benefit Analysis of Government Compensation of Kidney Donors.
    Held PJ; McCormick F; Ojo A; Roberts JP
    Am J Transplant; 2016 Mar; 16(3):877-85. PubMed ID: 26474298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine wars and policy provisions: how the landscape of organ procurement and allocation is changing in the United States.
    Wall A
    Curr Opin Organ Transplant; 2024 Jun; 29(3):173-174. PubMed ID: 38682655
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursing live organ donors for incurred non-medical expenses: a global perspective on policies and programs.
    Sickand M; Cuerden MS; Klarenbach SW; Ojo AO; Parikh CR; Boudville N; Garg AX;
    Am J Transplant; 2009 Dec; 9(12):2825-36. PubMed ID: 19788503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policies and practice of solid organ donation amongst people living with HIV in Canada: time for education and re-evaluation.
    Vulesevic B; Lauscher D; Kumar D; Sapir-Pichhadze R; Tchervenkov J; Angel JB; Wolfe C; Costiniuk CT
    HIV Res Clin Pract; 2024 Feb; 25(1):2323848. PubMed ID: 38529910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Deceased Donation: A Means Not an End.
    Stephan A
    Exp Clin Transplant; 2024 Apr; 22(Suppl 4):55. PubMed ID: 38775699
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we pay donors to increase the supply of organs for transplantation? No.
    Chapman J
    BMJ; 2008 Jun; 336(7657):1343. PubMed ID: 18556314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Assessing the value and cost of Organ Donation and Transplantation (ODT).
    Gitto L; Favi E; Giorgakis E; Cacciola R
    Front Public Health; 2024; 12():1388317. PubMed ID: 38566788
    [No Abstract]   [Full Text] [Related]  

  • 8. Social, economic, and policy implications of organ preservation advances.
    Ward A; Klassen DK; Franz KM; Giwa S; Lewis JK
    Curr Opin Organ Transplant; 2018 Jun; 23(3):336-346. PubMed ID: 29683801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal and ethical implications of NICE guidance aimed at optimising organ transplantation after circulatory death.
    Randall F; Downie R
    Clin Med (Lond); 2014 Feb; 14(1):92. PubMed ID: 24532759
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient's best interests and presumed consent in ante-mortem organ preservation in end-of-life care.
    Rady MY; Verheijde JL
    Clin Med (Lond); 2013 Dec; 13(6):630. PubMed ID: 24298120
    [No Abstract]   [Full Text] [Related]  

  • 11. Response.
    Littlejohns S; Littlejohns P; Richardson J; Robertson A
    Clin Med (Lond); 2014 Feb; 14(1):92. PubMed ID: 24532760
    [No Abstract]   [Full Text] [Related]  

  • 12. Response.
    Littlejohns S; Bontoft H; Littlejohns P; Richardson J; Robertson A
    Clin Med (Lond); 2013 Dec; 13(6):630-1. PubMed ID: 24298121
    [No Abstract]   [Full Text] [Related]  

  • 13. Employment effects of COVID-19 across Chilean regions: An application of the translog cost function.
    Modrego F; Canales A; Bahamonde H
    Reg Sci Policy Prac; 2020 Dec; 12(6):1151-1167. PubMed ID: 38607801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: Balancing Cost and Efficiency in Screening Potential Organ Donors With Whole Body CT.
    Mensink JW; Pol RA; Nijboer WN; de Vries KM; Alwayn IPJ; Braat AE
    Transplant Direct; 2020 Nov; 6(11):e623. PubMed ID: 33134499
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting.
    Hedley JA; Kelly PJ; Wyld M; Shah K; Morton RL; Byrnes J; Rosales BM; De La Mata NL; Wyburn K; Webster AC
    Transplant Direct; 2023 May; 9(5):e1474. PubMed ID: 37090124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of policies aimed at increasing organ donation: the case of Chile.
    Domínguez J; Harrison R; Atal R; Larraín L
    Transplant Proc; 2013; 45(10):3711-5. PubMed ID: 24315005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit estimation of cadaveric kidney transplantation: the case of a developing country.
    Domínguez J; Harrison R; Atal R
    Transplant Proc; 2011; 43(6):2300-4. PubMed ID: 21839259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Doha Donation Accord aligned with the Declaration of Istanbul: implementations to develop deceased organ donation and combat commercialism.
    Alkuwari H; Fadhil R; Almaslamani Y; Alansari A; Almalki H; Khalaf H; Ali O
    Transplantation; 2014 Jan; 97(1):3-4. PubMed ID: 24378648
    [No Abstract]   [Full Text] [Related]  

  • 19. Organ Transplantation in Greece.
    Moris D; Menoudakou G; Zavos G
    Transplantation; 2016 Aug; 100(8):1589-91. PubMed ID: 27454912
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.